# Evox Therapeutics

> Oxford, United Kingdom based biotechnology company developing genetic medicines that expand the reach of gene therapy into the brain. Its proprietary ExoEdit platform combines the natural transport capabilities of exosomes with CRISPR-based gene editing to improve the delivery, potency, and safety of treatments for severe neurodegenerative diseases such as Rett Syndrome. This is a company profile in the API Evangelist network; Evox does not currently publish a public developer API, SDK, or API documentation.

## Company
- [Website](https://www.evoxtherapeutics.com)
- [About Us](https://www.evoxtherapeutics.com/about-us/)
- [Pipeline](https://www.evoxtherapeutics.com/pipeline/)
- [Technology (ExoEdit)](https://www.evoxtherapeutics.com/technology/)
- [News](https://www.evoxtherapeutics.com/news/)
- [Careers](https://www.evoxtherapeutics.com/careers/)
- [Contact](https://www.evoxtherapeutics.com/contact/)
- [Privacy Policy](https://www.evoxtherapeutics.com/privacy-policy/)
- [LinkedIn](https://www.linkedin.com/company/evox-therapeutics-ltd/)

## APIs
- None published. Evox Therapeutics exposes no public API, SDK, or developer documentation at this time.